Literature DB >> 6848505

The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. Spin-labeling studies with chronically hypoxic and drug-resistant tumor cells.

J A Siegfried, K A Kennedy, A C Sartorelli, T R Tritton.   

Abstract

Electron spin resonance spectroscopy has been employed to analyze the changes in membrane order parameter in Sarcoma 180 cells under conditions in which an alteration in cellular susceptibility to the chemotherapeutic agent adriamycin is demonstrable. Changes in relative membrane fluidity using the paramagnetic probe 5-doxyl stearic acid were found to be associated with two phenomena which result in an altered cellular response to adriamycin: (a) the presence of an oxygen-deficient environment and (b) the expression of drug resistance. Under hypoxic conditions, in which the susceptibility to the cytotoxic action of adriamycin is increased, a decrease in bulk membrane order parameter was observed. Upon reoxygenation, the membrane fluidity and enhanced susceptibility to adriamycin reverted to control conditions with the same time course. In the case of drug-resistant cells, a progressive decrease in membrane fluidity was also observed which correlated with the degree of resistance to adriamycin. These data suggest that the physical alterations in the membrane reported by the spin label may be functionally linked to biological alterations in sensitivity to adriamycin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848505

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Medroxyprogesterone acetate increases anthracycline-induced lipid peroxidation and membrane fluidity.

Authors:  D d'Angelo; S Florio; L Crispino; R Ciarcia; G Pagnini
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

Review 2.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Intracellular distribution of anthracyclines in drug resistant cells.

Authors:  G Arancia; A Calcabrini; S Meschini; A Molinari
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

4.  Cardiotoxic effects of anthracyclines.

Authors:  M R Bristow
Journal:  West J Med       Date:  1983-09

5.  Cellular pharmacology and antitumor activity of N-(p-azidobenzoyl)-daunorubicin, a photoactive anthracycline analogue.

Authors:  S D Averbuch; R E Clawson; N R Bachur; R L Felsted
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure.

Authors:  Michael Fiegl; Ismael Samudio; Karen Clise-Dwyer; Jared K Burks; Zakar Mnjoyan; Michael Andreeff
Journal:  Blood       Date:  2008-10-28       Impact factor: 22.113

7.  Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line.

Authors:  Peter Bober; Michal Alexovic; Ivan Talian; Zuzana Tomkova; Zuzana Viscorova; Maria Benckova; Igor Andrasina; Rachele Ciccocioppo; Daniel Petrovic; Mariusz Adamek; Peter Kruzliak; Jan Sabo
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

Review 8.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

9.  In vivo effects of doxorubicin on kinase C in cultured cells.

Authors:  M Otsuka; H Shigeoka; H C Yang
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Expression of cell surface P-glycoprotein by an adriamycin-resistant murine fibrosarcoma.

Authors:  R Giavazzi; N Kartner; I R Hart
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.